Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Liver Diseases

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 81 articles:
HTML format



Single Articles


    June 2022
  1. WANG Y, Zhang Y, Mi J, Jiang C, et al
    ANKFN1 plays both protumorigenic and metastatic roles in hepatocellular carcinoma.
    Oncogene. 2022 Jun 21. pii: 10.1038/s41388-022-02380.
    PubMed     Abstract available


  2. MA XL, Zhu KY, Chen YD, Tang WG, et al
    Identification of a novel Calpain-2-SRC feed-back loop as necessity for beta-Catenin accumulation and signaling activation in hepatocellular carcinoma.
    Oncogene. 2022 Jun 13. pii: 10.1038/s41388-022-02367.
    PubMed     Abstract available


  3. LIU Y, Ouyang L, Mao C, Chen Y, et al
    PCDHB14 promotes ferroptosis and is a novel tumor suppressor in hepatocellular carcinoma.
    Oncogene. 2022 Jun 10. pii: 10.1038/s41388-022-02370.
    PubMed     Abstract available


    May 2022
  4. CHEN S, Cheng J, Zhong Y, Liu R, et al
    Correction: Liver-specific overexpression of Gab2 accelerates hepatocellular carcinoma progression by activating immunosuppression of myeloid-derived suppressor cells.
    Oncogene. 2022 May 6. pii: 10.1038/s41388-022-02337.
    PubMed    


    April 2022
  5. LI K, Niu Y, Yuan Y, Qiu J, et al
    Insufficient ablation induces E3-ligase Nedd4 to promote hepatocellular carcinoma progression by tuning TGF-beta signaling.
    Oncogene. 2022 Apr 30. pii: 10.1038/s41388-022-02334.
    PubMed     Abstract available


  6. CHEN J, Li Z, Jia X, Song W, et al
    Targeting anillin inhibits tumorigenesis and tumor growth in hepatocellular carcinoma via impairing cytokinesis fidelity.
    Oncogene. 2022 Apr 27. pii: 10.1038/s41388-022-02274.
    PubMed     Abstract available


  7. TSAI YT, Li CY, Huang YH, Chang TS, et al
    Galectin-1 orchestrates an inflammatory tumor-stroma crosstalk in hepatoma by enhancing TNFR1 protein stability and signaling in carcinoma-associated fibroblasts.
    Oncogene. 2022 Apr 22. pii: 10.1038/s41388-022-02309.
    PubMed     Abstract available


  8. HOCHNADEL I, Hoenicke L, Petriv N, Neubert L, et al
    Correction: Safety and efficacy of prophylactic and therapeutic vaccine based on live-attenuated Listeria monocytogenes in hepatobiliary cancers.
    Oncogene. 2022 Apr 13. pii: 10.1038/s41388-022-02261.
    PubMed    


  9. CHEN S, Cheng J, Zhong Y, Liu R, et al
    Liver-specific overexpression of Gab2 accelerates hepatocellular carcinoma progression by activating immunosuppression of myeloid-derived suppressor cells.
    Oncogene. 2022 Apr 11. pii: 10.1038/s41388-022-02298.
    PubMed     Abstract available


    March 2022
  10. CHEN X, Wang Z, Zhao X, Zhang L, et al
    STAT5A modulates CDYL2/SLC7A6 pathway to inhibit the proliferation and invasion of hepatocellular carcinoma by targeting to mTORC1.
    Oncogene. 2022 Mar 21. pii: 10.1038/s41388-022-02273.
    PubMed     Abstract available


  11. GU Y, Guo Y, Gao N, Fang Y, et al
    The proteomic characterization of the peritumor microenvironment in human hepatocellular carcinoma.
    Oncogene. 2022 Mar 21. pii: 10.1038/s41388-022-02264.
    PubMed     Abstract available


  12. WU WR, Shi XD, Zhang FP, Zhu K, et al
    Activation of the Notch1-c-myc-VCAM1 signalling axis initiates liver progenitor cell-driven hepatocarcinogenesis and pulmonary metastasis.
    Oncogene. 2022 Mar 7. pii: 10.1038/s41388-022-02246.
    PubMed     Abstract available


  13. LV B, Pan Y, Hou D, Chen P, et al
    RNF4 silencing induces cell growth arrest and DNA damage by promoting nuclear targeting of p62 in hepatocellular carcinoma.
    Oncogene. 2022 Mar 2. pii: 10.1038/s41388-022-02247.
    PubMed     Abstract available


  14. HAN L, Lin X, Yan Q, Gu C, et al
    PBLD inhibits angiogenesis via impeding VEGF/VEGFR2-mediated microenvironmental cross-talk between HCC cells and endothelial cells.
    Oncogene. 2022;41:1851-1865.
    PubMed     Abstract available


  15. RAO VS, Gu Q, Tzschentke S, Lin K, et al
    Extravesicular TIMP-1 is a non-invasive independent prognostic marker and potential therapeutic target in colorectal liver metastases.
    Oncogene. 2022;41:1809-1820.
    PubMed     Abstract available


  16. JOURNO S, Goldberg AK, Sokol ES, Zinger L, et al
    Genomic alterations drive metastases formation in pancreatic ductal adenocarcinoma cancer: deciphering the role of CDKN2A and CDKN2B in mediating liver tropism.
    Oncogene. 2022;41:1468-1481.
    PubMed     Abstract available


    February 2022
  17. JI X, Chen X, Zhang B, Xie M, et al
    T-box transcription factor 19 promotes hepatocellular carcinoma metastasis through upregulating EGFR and RAC1.
    Oncogene. 2022 Feb 26. pii: 10.1038/s41388-022-02249.
    PubMed     Abstract available


  18. HOCHNADEL I, Hoenicke L, Petriv N, Neubert L, et al
    Safety and efficacy of prophylactic and therapeutic vaccine based on live-attenuated Listeria monocytogenes in hepatobiliary cancers.
    Oncogene. 2022 Feb 16. pii: 10.1038/s41388-022-02222.
    PubMed     Abstract available


  19. LI B, Kang H, Xiao Y, Du Y, et al
    LncRNA GAL promotes colorectal cancer liver metastasis through stabilizing GLUT1.
    Oncogene. 2022 Feb 11. pii: 10.1038/s41388-022-02230.
    PubMed     Abstract available


  20. ZHANG X, Hu Y, Pan Y, Xiong Y, et al
    DDR1 promotes hepatocellular carcinoma metastasis through recruiting PSD4 to ARF6.
    Oncogene. 2022 Feb 9. pii: 10.1038/s41388-022-02212.
    PubMed     Abstract available


  21. DESI N, Teh V, Tong QY, Lim CY, et al
    MiR-138 is a potent regulator of the heterogenous MYC transcript population in cancers.
    Oncogene. 2022;41:1178-1189.
    PubMed     Abstract available


    January 2022
  22. XU QC, Tien YC, Shi YH, Chen S, et al
    METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m(6)A-YTHDF2-dependent manner.
    Oncogene. 2022 Jan 29. pii: 10.1038/s41388-022-02185.
    PubMed     Abstract available


  23. CHIAVARINA B, Ronca R, Otaka Y, Sutton RB, et al
    Fibroblast-derived prolargin is a tumor suppressor in hepatocellular carcinoma.
    Oncogene. 2022 Jan 14. pii: 10.1038/s41388-021-02171.
    PubMed     Abstract available


  24. HE DD, Shang XY, Wang N, Wang GX, et al
    BRD4 inhibition induces synthetic lethality in ARID2-deficient hepatocellular carcinoma by increasing DNA damage.
    Oncogene. 2022 Jan 11. pii: 10.1038/s41388-022-02176.
    PubMed     Abstract available


    December 2021
  25. LIU R, Gou D, Xiang J, Pan X, et al
    O-GlcNAc modified-TIP60/KAT5 is required for PCK1 deficiency-induced HCC metastasis.
    Oncogene. 2021;40:6707-6719.
    PubMed     Abstract available


    November 2021
  26. SUN L, Xi S, Zhou Z, Zhang F, et al
    Elevated expression of RIT1 hyperactivates RAS/MAPK signal and sensitizes hepatocellular carcinoma to combined treatment with sorafenib and AKT inhibitor.
    Oncogene. 2021 Nov 29. pii: 10.1038/s41388-021-02130.
    PubMed     Abstract available


  27. GILL T, Wang H, Bandaru R, Lawlor M, et al
    Selective targeting of MYC mRNA by stabilized antisense oligonucleotides.
    Oncogene. 2021;40:6527-6539.
    PubMed     Abstract available


    September 2021
  28. LI B, Xia Y, Lv J, Wang W, et al
    miR-151a-3p-rich small extracellular vesicles derived from gastric cancer accelerate liver metastasis via initiating a hepatic stemness-enhancing niche.
    Oncogene. 2021 Sep 17. pii: 10.1038/s41388-021-02011.
    PubMed     Abstract available


  29. LU L, Zhang J, Fan W, Li Y, et al
    Deregulated 14-3-3zeta and methionine adenosyltransferase alpha1 interplay promotes liver cancer tumorigenesis in mice and humans.
    Oncogene. 2021;40:5866-5879.
    PubMed     Abstract available


  30. ZHANG X, Dou P, Akhtar ML, Liu F, et al
    NEU4 inhibits motility of HCC cells by cleaving sialic acids on CD44.
    Oncogene. 2021;40:5427-5440.
    PubMed     Abstract available


    August 2021
  31. QIU P, Hou W, Wang H, Lei KKW, et al
    Sirt1 deficiency upregulates glutathione metabolism to prevent hepatocellular carcinoma initiation in mice.
    Oncogene. 2021 Aug 25. pii: 10.1038/s41388-021-01993.
    PubMed     Abstract available


  32. SHERMAN J, Verstandig G, Brumer Y
    Application of machine learning to large in-vitro databases to identify cancer cell characteristics: telomerase reverse transcriptase (TERT) expression.
    Oncogene. 2021;40:5038-5041.
    PubMed     Abstract available


    July 2021
  33. LIU Z, Wang A, Pu Y, Li Z, et al
    Genomic and transcriptomic profiling of hepatoid adenocarcinoma of the stomach.
    Oncogene. 2021 Jul 30. pii: 10.1038/s41388-021-01976.
    PubMed     Abstract available


  34. ZHANG Y, Yan Q, Gong L, Xu H, et al
    Correction: C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism.
    Oncogene. 2021 Jul 26. pii: 10.1038/s41388-021-01942.
    PubMed    


  35. BRAHMA MK, Gilglioni EH, Zhou L, Trepo E, et al
    Oxidative stress in obesity-associated hepatocellular carcinoma: sources, signaling and therapeutic challenges.
    Oncogene. 2021 Jul 21. pii: 10.1038/s41388-021-01950.
    PubMed     Abstract available


  36. ZHANG EB, Zhang X, Wang K, Zhang F, et al
    Antifungal agent Terbinafine restrains tumor growth in preclinical models of hepatocellular carcinoma via AMPK-mTOR axis.
    Oncogene. 2021 Jul 10. pii: 10.1038/s41388-021-01934.
    PubMed     Abstract available


  37. XU F, Jiang L, Zhao Q, Zhang Z, et al
    Whole-transcriptome and proteome analyses identify key differentially expressed mRNAs, miRNAs, lncRNAs and circRNAs associated with HCC.
    Oncogene. 2021;40:4820-4831.
    PubMed     Abstract available


    June 2021
  38. ZHAO S, Guan B, Mi Y, Shi D, et al
    LncRNA MIR17HG promotes colorectal cancer liver metastasis by mediating a glycolysis-associated positive feedback circuit.
    Oncogene. 2021 Jun 18. pii: 10.1038/s41388-021-01859.
    PubMed     Abstract available


  39. LIN YH, Wu MH, Liu YC, Lyu PC, et al
    LINC01348 suppresses hepatocellular carcinoma metastasis through inhibition of SF3B3-mediated EZH2 pre-mRNA splicing.
    Oncogene. 2021 Jun 17. pii: 10.1038/s41388-021-01905.
    PubMed     Abstract available


  40. WANG S, Cao K, Liao Y, Zhang W, et al
    CDCA2 protects against oxidative stress by promoting BRCA1-NRF2 signaling in hepatocellular carcinoma.
    Oncogene. 2021 Jun 8. pii: 10.1038/s41388-021-01855.
    PubMed     Abstract available


  41. WANG X, Dong J, Li X, Cheng Z, et al
    CPSF4 regulates circRNA formation and microRNA mediated gene silencing in hepatocellular carcinoma.
    Oncogene. 2021 Jun 8. pii: 10.1038/s41388-021-01867.
    PubMed     Abstract available


  42. SHEN M, Zhang R, Jia W, Zhu Z, et al
    Nuclear scaffold protein p54(nrb)/NONO facilitates the hypoxia-enhanced progression of hepatocellular carcinoma.
    Oncogene. 2021 Jun 2. pii: 10.1038/s41388-021-01848.
    PubMed     Abstract available


  43. WANG Y, Yu H, Xie X, Deng T, et al
    Plasmalemma vesicle-associated protein promotes angiogenesis in cholangiocarcinoma via the DKK1/CKAP4/PI3K signaling pathway.
    Oncogene. 2021;40:4324-4337.
    PubMed     Abstract available


    May 2021
  44. CAROTTI S, Zingariello M, Francesconi M, D'Andrea L, et al
    Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge.
    Oncogene. 2021 May 20. pii: 10.1038/s41388-021-01824.
    PubMed     Abstract available


  45. ZHANG XL, Hu LP, Yang Q, Qin WT, et al
    CTHRC1 promotes liver metastasis by reshaping infiltrated macrophages through physical interactions with TGF-beta receptors in colorectal cancer.
    Oncogene. 2021 May 13. pii: 10.1038/s41388-021-01827.
    PubMed     Abstract available


    April 2021
  46. CHEN S, Du Y, Xu B, Li Q, et al
    Vaccinia-related kinase 2 blunts sorafenib's efficacy against hepatocellular carcinoma by disturbing the apoptosis-autophagy balance.
    Oncogene. 2021 Apr 19. pii: 10.1038/s41388-021-01780.
    PubMed     Abstract available


  47. CHEN K, Hou Y, Liao R, Li Y, et al
    LncRNA SNHG6 promotes G1/S-phase transition in hepatocellular carcinoma by impairing miR-204-5p-mediated inhibition of E2F1.
    Oncogene. 2021 Apr 6. pii: 10.1038/s41388-021-01671.
    PubMed     Abstract available


  48. LAO M, Zhang X, Ma T, Xu J, et al
    Regulator of calcineurin 1 gene isoform 4 in pancreatic ductal adenocarcinoma regulates the progression of tumor cells.
    Oncogene. 2021;40:3136-3151.
    PubMed     Abstract available


    March 2021
  49. ZHANG G, Yang Y, Hu H, Liu K, et al
    Energy stress-induced linc01564 activates the serine synthesis pathway and facilitates hepatocellular carcinogenesis.
    Oncogene. 2021 Mar 19. pii: 10.1038/s41388-021-01749.
    PubMed     Abstract available


  50. JING CY, Fu YP, Zhou C, Zhang MX, et al
    Hepatic stellate cells promote intrahepatic cholangiocarcinoma progression via NR4A2/osteopontin/Wnt signaling axis.
    Oncogene. 2021 Mar 19. pii: 10.1038/s41388-021-01705.
    PubMed     Abstract available


  51. PAN Z, Liu C, Zhi Y, Xie Z, et al
    LIMK1 nuclear translocation promotes hepatocellular carcinoma progression by increasing p-ERK nuclear shuttling and by activating c-Myc signalling upon EGF stimulation.
    Oncogene. 2021 Mar 8. pii: 10.1038/s41388-021-01736.
    PubMed     Abstract available


  52. ALASADI A, Cao B, Guo J, Tao H, et al
    Mitochondrial uncoupler MB1-47 is efficacious in treating hepatic metastasis of pancreatic cancer in murine tumor transplantation models.
    Oncogene. 2021 Mar 1. pii: 10.1038/s41388-021-01688.
    PubMed     Abstract available


    February 2021
  53. LUO JH, Liu S, Tao J, Ren BG, et al
    Pten-NOLC1 fusion promotes cancers involving MET and EGFR signalings.
    Oncogene. 2021;40:1064-1076.
    PubMed     Abstract available


    January 2021
  54. LU Y, Li X, Liu H, Xue J, et al
    beta-Trcp and CK1delta-mediated degradation of LZTS2 activates PI3K/AKT signaling to drive tumorigenesis and metastasis in hepatocellular carcinoma.
    Oncogene. 2021 Jan 8. pii: 10.1038/s41388-020-01596.
    PubMed     Abstract available


    December 2020
  55. ZHANG Y, Yan Q, Gong L, Xu H, et al
    C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism.
    Oncogene. 2020 Dec 15. pii: 10.1038/s41388-020-01593.
    PubMed     Abstract available


    November 2020
  56. YAO L, Xuan Y, Zhang H, Yang B, et al
    Reciprocal REGgamma-mTORC1 regulation promotes glycolytic metabolism in hepatocellular carcinoma.
    Oncogene. 2020 Nov 23. pii: 10.1038/s41388-020-01558.
    PubMed     Abstract available


  57. YU J, Wang N, Gong Z, Liu L, et al
    Cytochrome P450 1A2 overcomes nuclear factor kappa B-mediated sorafenib resistance in hepatocellular carcinoma.
    Oncogene. 2020 Nov 12. pii: 10.1038/s41388-020-01545.
    PubMed     Abstract available


    October 2020
  58. LIU C, Zhou X, Long Q, Zeng H, et al
    Small extracellular vesicles containing miR-30a-3p attenuate the migration and invasion of hepatocellular carcinoma by targeting SNAP23 gene.
    Oncogene. 2020 Oct 27. pii: 10.1038/s41388-020-01521.
    PubMed     Abstract available


  59. NIMMAKAYALA RK, Leon F, Rachagani S, Rauth S, et al
    Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma.
    Oncogene. 2020 Oct 27. pii: 10.1038/s41388-020-01518.
    PubMed     Abstract available


  60. CHEN J, Xuan Z, Song W, Han W, et al
    EAG1 enhances hepatocellular carcinoma proliferation by modulating SKP2 and metastasis through pseudopod formation.
    Oncogene. 2020 Oct 24. pii: 10.1038/s41388-020-01522.
    PubMed     Abstract available


  61. VON FELDEN J, Craig AJ, Garcia-Lezana T, Labgaa I, et al
    Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma.
    Oncogene. 2020 Oct 23. pii: 10.1038/s41388-020-01519.
    PubMed     Abstract available


  62. GAMAEV L, Mizrahi L, Friehmann T, Rosenberg N, et al
    The pro-oncogenic effect of the lncRNA H19 in the development of chronic inflammation-mediated hepatocellular carcinoma.
    Oncogene. 2020 Oct 22. pii: 10.1038/s41388-020-01513.
    PubMed     Abstract available


  63. YAN Y, Huang P, Mao K, He C, et al
    Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression.
    Oncogene. 2020 Oct 13. pii: 10.1038/s41388-020-01498.
    PubMed     Abstract available


  64. HE Q, Lin Z, Wang Z, Huang W, et al
    SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-MET.
    Oncogene. 2020 Oct 12. pii: 10.1038/s41388-020-01500.
    PubMed     Abstract available


    September 2020
  65. SUN Z, Xue S, Zhang M, Xu H, et al
    Aberrant NSUN2-mediated m(5)C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma.
    Oncogene. 2020 Sep 25. pii: 10.1038/s41388-020-01475.
    PubMed     Abstract available


  66. YANG B, Feng X, Liu H, Tong R, et al
    High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma.
    Oncogene. 2020 Sep 11. pii: 10.1038/s41388-020-01450.
    PubMed     Abstract available


  67. ZHOU Q, Huang T, Jiang Z, Ge C, et al
    Correction: Upregulation of SNX5 predicts poor prognosis and promotes hepatocellular carcinoma progression by modulating the EGFR-ERK1/2 signaling pathway.
    Oncogene. 2020 Sep 7. pii: 10.1038/s41388-020-01440.
    PubMed     Abstract available


    August 2020
  68. WU D, Wang Y, Yang G, Zhang S, et al
    A novel mitochondrial amidoxime reducing component 2 is a favorable indicator of cancer and suppresses the progression of hepatocellular carcinoma by regulating the expression of p27.
    Oncogene. 2020 Aug 18. pii: 10.1038/s41388-020-01417.
    PubMed     Abstract available


  69. BARTOLOME RA, Pintado-Berninches L, Jaen M, de Los Rios V, et al
    SOSTDC1 promotes invasion and liver metastasis in colorectal cancer via interaction with ALCAM/CD166.
    Oncogene. 2020 Aug 15. pii: 10.1038/s41388-020-01419.
    PubMed     Abstract available


    July 2020
  70. SHI X, Liu TT, Yu XN, Balakrishnan A, et al
    microRNA-93-5p promotes hepatocellular carcinoma progression via a microRNA-93-5p/MAP3K2/c-Jun positive feedback circuit.
    Oncogene. 2020 Jul 27. pii: 10.1038/s41388-020-01401.
    PubMed     Abstract available


  71. FENG H, Liu J, Qiu Y, Liu Y, et al
    RNA-binding motif protein 43 (RBM43) suppresses hepatocellular carcinoma progression through modulation of cyclin B1 expression.
    Oncogene. 2020 Jul 6. pii: 10.1038/s41388-020-1380.
    PubMed     Abstract available


    May 2020
  72. TSAI CN, Yu SC, Lee CW, Pang JS, et al
    SOX4 activates CXCL12 in hepatocellular carcinoma cells to modulate endothelial cell migration and angiogenesis in vivo.
    Oncogene. 2020 May 13. pii: 10.1038/s41388-020-1319.
    PubMed     Abstract available


  73. HUANG WJ, Tian XP, Bi SX, Zhang SR, et al
    The beta-catenin/TCF-4-LINC01278-miR-1258-Smad2/3 axis promotes hepatocellular carcinoma metastasis.
    Oncogene. 2020 May 5. pii: 10.1038/s41388-020-1307.
    PubMed     Abstract available


  74. ZHANG C, Huang S, Zhuang H, Ruan S, et al
    YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
    Oncogene. 2020 May 4. pii: 10.1038/s41388-020-1303.
    PubMed     Abstract available


  75. WILLIAMS M, Liu X, Zhang Y, Reske J, et al
    NCOA5 deficiency promotes a unique liver protumorigenic microenvironment through p21(WAF1/CIP1) overexpression, which is reversed by metformin.
    Oncogene. 2020;39:3821-3836.
    PubMed     Abstract available


    April 2020
  76. TIAN L, Yao K, Liu K, Han B, et al
    PLK1/NF-kappaB feedforward circuit antagonizes the mono-ADP-ribosyltransferase activity of PARP10 and facilitates HCC progression.
    Oncogene. 2020;39:3145-3162.
    PubMed     Abstract available


    March 2020
  77. HSU BE, Roy J, Mouhanna J, Rayes RF, et al
    C3a elicits unique migratory responses in immature low-density neutrophils.
    Oncogene. 2020;39:2612-2623.
    PubMed     Abstract available


  78. XIAO Y, Liu G, Sun Y, Gao Y, et al
    Targeting the estrogen receptor alpha (ERalpha)-mediated circ-SMG1.72/miR-141-3p/Gelsolin signaling to better suppress the HCC cell invasion.
    Oncogene. 2020;39:2493-2508.
    PubMed     Abstract available


  79. SAKSOUK N, Hajdari S, Perez Y, Pratlong M, et al
    The mouse HP1 proteins are essential for preventing liver tumorigenesis.
    Oncogene. 2020;39:2676-2691.
    PubMed     Abstract available


    February 2020
  80. DAI K, Tanaka M, Kamiyoshi A, Sakurai T, et al
    Deficiency of the adrenomedullin-RAMP3 system suppresses metastasis through the modification of cancer-associated fibroblasts.
    Oncogene. 2020;39:1914-1930.
    PubMed     Abstract available


    January 2020
  81. OUAHOUD S, Voorneveld PW, van der Burg LRA, de Jonge-Muller ESM, et al
    Bidirectional tumor/stroma crosstalk promotes metastasis in mesenchymal colorectal cancer.
    Oncogene. 2020 Jan 23. pii: 10.1038/s41388-020-1157.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: